MENU
ITOS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
iTeos Therapeutics (ITOS) Ownership - Who owns iTeos Therapeutics?
ITeos Therapeutics Inc is a biopharmaceutical company... Show more
Profile
Industry
N/A
Address
321 Arsenal Street
Phone
+1 339 217-0162
Employees
157
Web
https://www.iteostherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
445.91M
P/E Ratio
N/A
Total Cash
520.37M
Projected Growth
N/A
Total Debt
5.05M
Revenue
35M
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash/Share
11.78
Total Debt/Equity
N/A
Revenue/Share
0.83 USD as % of share price
Fundamentals
ITOS
Capitalization
446M
P/E Ratio
N/A
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash
520M
Total Cash/Share
11.78
Total Debt
5.05M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.83%
Revenue
35M
ROE
N/A
Book Value
563M
P/B Ratio
0.79
Cash Flow
N/A
Earnings
-3.05
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
38K
Current Ratio
14.13
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-146.71M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-20.30
Shares Held By Institutions
331M
Shares Outstanding - Current
44.2M
Total Liabilities
95.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
31.380
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ITOS showed earnings on April 28, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a company, which engages in the development of biopharmaceuticals therapeutic products and services
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
321 Arsenal Street
Phone
+1 339 217-0162
Employees
157
Web
https://www.iteostherapeutics.com